Acalabrutinib + Rifampin Interaction
Majorinteraction on record
Description
Strong CYP3A inducer decreases acalabrutinib plasma concentrations, reducing CALQUENCE activity. Avoid co-administration or increase acalabrutinib dose to 200 mg every 12 hours if unavoidable.
Mechanism
CYP3A induction
Source: NLP:acalabrutinib